Cancer therapy developer Lava Therapeutics has raised $18.6m in a round featuring Merck Research Laboratories unit MRL Ventures.

Speaking at the GCV Symposium, Scott Caruso, director of strategic ventures at UpRamp, said that latency, infrastructure and content will be key VC drivers for the media sector.

Fred Hutchinson Cancer Research Center is the third institution to gain an academic bridge program in collaboration with Evotec, with the latest instalment dubbed Lab591.

Two years after investing a reported $7m in the robo-advisor developer, Allianz Asset Management has returned to lead a $53.1m round.

InnovAllianz, an investment subsidiary of Allianz, has contributed to a $15m funding round for 3D organ printing company Biomodex.

The mining and steel company has formed a subsidiary called Severstal Ventures that will invest in startups and funds.

The cryptocurrency wallet and trading platform, backed by Credit Saison and OKWave in its last round, secured the cash through VC funding and a crowdsale.